Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Clinical trial NCT00095394 · COMPLETED
Trial details
- NCT number
- NCT00095394
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2005-05-01
- Enrollment
- 645
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.